Moving Towards Personalized Approach In Multiple Myeloma

This program was made possible by unrestricted sponsorship support from Amgen.

This program was made possible by unrestricted sponsorship support from Amgen.

Multiple Myeloma: Treatment at First Relapse

BOOE 2020 - Lunch Symposium (Mylan) - The Future of Biosimilars in Oncology - Implementing the Lessons from Today

BOOE 2020 - Breast Cancer

BOOE 2020 - Radiation Oncology Update: Management of Oligometastases

BOOE 2020 - GU - Prostate and Non-Prostate

BOOE 2020 - Melanoma

BOOE 2020 - Lung Cancer

Speaker: Dr. Barry Stein Chair: Dr. Sharlene Gill

Speaker: Dr. Barry Stein Chair: Dr. Sharlene Gill

How to Communicate Treatment Choices for mCRC - A Physician and Patient Perspective

Featuring Dr. Dr. Marcus Butler, Dr. Michael Smylie, and Dr. Jason Luke Trials Discussed:     Metastatic/Advanced Melanoma: COMBI-i Trial, LEAP-004 and SECOMBIT  Adjuvant Trials in Melanoma: KEYNOTE 054 and CheckMate 238 Metastatic/Advanced Melanoma: Local Therapy in Solitary Melanoma, NIVO+IPI vs NIVO and ILLUMINATE-204  Non-Melanoma Skin Cancer: PD1 Blockage in Kaposi Sarcoma  This podcast has been made available through sponsorship from BMS.

Featuring Dr. Dr. Marcus Butler, Dr. Michael Smylie, and Dr. Jason Luke Trials Discussed:  <ul> <li>Metastatic/Advanced Melanoma: COMBI-i Trial, LEAP-004 and SECOMBIT </li> <li>Adjuvant Trials in Melanoma: KEYNOTE 054 and CheckMate 238</li> <li>Metastatic/Advanced Melanoma: Local Therapy in Solitary Melanoma, NIVO+IPI vs NIVO and ILLUMINATE-204 </li> <li>Non-Melanoma Skin Cancer: PD1 Blockage in Kaposi Sarcoma</li> </ul> This podcast has been made available through sponsorship from BMS.

Highlights from ESMO 2020: Skin Cancer (Melanoma and Non-Melanoma)

Welcome to the Best of Oncology podcast series, brought to you by OncologyEducation.  Join our medical oncology experts as they discuss clinical implications of the latest advances and the hottest topics in the treatment and management of cancer.

Best of Oncology Podcast Series

In this episode, we'll listen to Dr. Srikala Sridhar, Dr. Scott North and Dr. Alicia Morgans discuss the important trials presented at ASCO 2019. 01:01 -  ENZAMET Study  12:49  - TITAN Study 19:00  - KEYNOTE-426 Study 28:25  - CALGB 90601 (Alliance) 38:29  - HCRN:GU14-182

In this episode, we'll listen to Dr. Srikala Sridhar, Dr. Scott North and Dr. Alicia Morgans discuss the important trials presented at ASCO 2019. 01:01 -  ENZAMET Study  12:49  - TITAN Study 19:00  - KEYNOTE-426 Study 28:25  - CALGB 90601 (Alliance) 38:29  - HCRN:GU14-182

Highlights from the 2019 ASCO Annual Meeting - Genitourinary Cancer

In this episode, we'll listen to Dr. Sunil Verma, Dr. Hope Rugo and Dr. Peter Schmid discuss the important trials presented at ASCO 2019. 01:01 - Her 2 Positive Breast Cancer 18:59 - Hormone Receptor Positive 37:37 - Triple Negative Breast Cancer and Immunotherapy

In this episode, we'll listen to Dr. Sunil Verma, Dr. Hope Rugo and Dr. Peter Schmid discuss the important trials presented at ASCO 2019. 01:01 - Her 2 Positive Breast Cancer 18:59 - Hormone Receptor Positive 37:37 - Triple Negative Breast Cancer and Immunotherapy

Highlights from the 2019 ASCO Annual Meeting - Breast Cancer

In this episode we’ll listen in on a conversation that Dr. Sunil Verma, Medical Director of the Tom Baker Cancer Centre, Dr. Sara Tolaney Associate Director of the Susan F. Smith Center for Women's Cancers at the Dana Farber Cancer Institute, and Dr. Christine Simmons Medical Oncologist with the British Columbia Cancer Agency, had at the 2019 Best of San Antonio Breast Cancer Symposium in Toronto, where they shared their thoughts on the most impactful data released in Triple Negative Breast Cancer at the flagship meeting a few weeks earlier.

In this episode we’ll listen in on a conversation that Dr. Sunil Verma, Medical Director of the Tom Baker Cancer Centre, Dr. Sara Tolaney Associate Director of the Susan F. Smith Center for Women's Cancers at the Dana Farber Cancer Institute, and Dr. Christine Simmons Medical Oncologist with the British Columbia Cancer Agency, had at the 2019 Best of San Antonio Breast Cancer Symposium in Toronto, where they shared their thoughts on the most impactful data released in Triple Negative Breast Cancer at the flagship meeting a few weeks earlier.

 Highlights from the 2018 San Antonio Breast Cancer Symposium - Triple Negative Breast Cancer

In this episode, we'll listen to Dr. Barb Melosky, Dr. Sanjay Popat and Dr. Parneet Cheema discuss the important trials presented at ASCO 2019. 01:06 - Relay Trial 07:23 - GEFITNIB Phase III Trial 14:40 - TAK-788 20:00 - Geometry and TEPOTINIB Study 26:48 - Adjuvant Therapy

In this episode, we'll listen to Dr. Barb Melosky, Dr. Sanjay Popat and Dr. Parneet Cheema discuss the important trials presented at ASCO 2019. 01:06 - Relay Trial 07:23 - GEFITNIB Phase III Trial 14:40 - TAK-788 20:00 - Geometry and TEPOTINIB Study 26:48 - Adjuvant Therapy

Highlights from the 2019 ASCO Annual Meeting - Lung Cancer

In this episode, we'll listen to Dr. Scott Berry, Dr. Marc Peeters and Dr. Sharlene Gill, discuss the important trials presented at ASCO 2019. 08:20 - Apact Trial 16:35 - Phase 3 Trial of 1st Line Chemo vs Pembrolizumab vs Chemo + Pembrolizumab for Metastatic Gastric CA 24:15 - Phase 3 Trial of 2nd Line Pembrolizumab vs Placebo for HCC 30:26 - ABC-06 35:35 - IDEA Study (High Risk Stage 2 Patients) 46:19 - Foxtrot Trial

In this episode, we'll listen to Dr. Scott Berry, Dr. Marc Peeters and Dr. Sharlene Gill, discuss the important trials presented at ASCO 2019. 08:20 - Apact Trial 16:35 - Phase 3 Trial of 1st Line Chemo vs Pembrolizumab vs Chemo + Pembrolizumab for Metastatic Gastric CA 24:15 - Phase 3 Trial of 2nd Line Pembrolizumab vs Placebo for HCC 30:26 - ABC-06 35:35 - IDEA Study (High Risk Stage 2 Patients) 46:19 - Foxtrot Trial

Highlights from the 2019 ASCO Annual Meeting - Gastrointestinal Cancers

In this episode, we'll listen to Dr. Gwyn Bebb, Dr. Daniel Renouf and Dr. Sebastien Hotte discuss the important trials presented at ASCO 2019. 01:11 - Broad Indications for Small Molecular Inhibitors, and DNA repair deficiency 26:56 - Broad Indications for Immunotherapy

In this episode, we'll listen to Dr. Gwyn Bebb, Dr. Daniel Renouf and Dr. Sebastien Hotte discuss the important trials presented at ASCO 2019. 01:11 - Broad Indications for Small Molecular Inhibitors, and DNA repair deficiency 26:56 - Broad Indications for Immunotherapy

Highlights from the 2019 ASCO Annual Meeting - Pan Tumour

In this episode, we'll listen to Dr. Heather McArthur, Dr. Hope Rugo and Dr. Veronique Dieras discuss the important trials presented at ESMO 2019. 00:01 Introduction of the Best of Oncology Podcast 00:26 Introduction of Dr. Heather McArthur, Dr. Hope Rugo and Dr. Veronique Dieras 01:12 KEYNOTE-522 15:05 Targeted therapy and Immunotherapy in Breast Cancer 33:00 HER 2 + Metastatic Breast Cancer Updates 41:49 Hormone Receptor Positive Breast Cancer Updates

In this episode, we'll listen to Dr. Heather McArthur, Dr. Hope Rugo and Dr. Veronique Dieras discuss the important trials presented at ESMO 2019. 00:01 Introduction of the Best of Oncology Podcast 00:26 Introduction of Dr. Heather McArthur, Dr. Hope Rugo and Dr. Veronique Dieras 01:12 KEYNOTE-522 15:05 Targeted therapy and Immunotherapy in Breast Cancer 33:00 HER 2 + Metastatic Breast Cancer Updates 41:49 Hormone Receptor Positive Breast Cancer Updates

Highlights from the 2019 ESMO Annual Meeting -  Breast Cancer

Andrew Robinson

Joshua Bauml

Oncologists Dr. Andrew Robinson and Dr. Joshua Bauml, in conversation at the 2019 Eastern Canadian Oncology Opinion Series, discuss their experience with the changing landscapes in cancer care.

Oncologists Dr. Andrew Robinson and Dr. Joshua Bauml, in conversation at the 2019 Eastern Canadian Oncology Opinion Series, discuss their experience with the changing landscapes in cancer care.

Oncologists Dr. Andrew Robinson and Dr. Joshua Bauml discuss cancer care

Kevin Song

Meletios Dimopolous

Oncologists Dr. Kevin Song and Dr. Meletios Dimopolous discuss multiple myeloma.

Oncologists Dr. Kevin Song and Dr. Meletios Dimopolous discuss multiple myeloma.

Dr. Kevin Song and Dr. Meletios Dimopolous discuss multiple myeloma

In this episode, we'll listen to Dr. Daniel Renouf, Dr. Jose Monzon and Dr. Jonathan Loree discuss precision medicine at ESMO 2019. 00:01 Introduction of the Best of Oncology Podcast 00:27 Introduction of Dr. Daniel Renouf, Dr. Jose Monzon and Dr. Jonathan Loree 01:22 Phase I Study of AMG 510 10:37 Abstract 528PD: Correlative analysis of CCTG CO.26 18:33 Abstract LBA30_PR: Correlative analysis of IDEA-FRANCE phase III trial 25:11 Abstract: LBA15_PR 33:20 TRK Fusion Updates 43:27 Discussion: The Future of Precision Medicine

In this episode, we'll listen to Dr. Daniel Renouf, Dr. Jose Monzon and Dr. Jonathan Loree discuss precision medicine at ESMO 2019. 00:01 Introduction of the Best of Oncology Podcast 00:27 Introduction of Dr. Daniel Renouf, Dr. Jose Monzon and Dr. Jonathan Loree 01:22 Phase I Study of AMG 510 10:37 Abstract 528PD: Correlative analysis of CCTG CO.26 18:33 Abstract LBA30_PR: Correlative analysis of IDEA-FRANCE phase III trial 25:11 Abstract: LBA15_PR 33:20 TRK Fusion Updates 43:27 Discussion: The Future of Precision Medicine

Highlights from the 2019 ESMO Annual Meeting - Precision Medicine

In this episode, we'll listen to Dr. Barbara Melosky, Dr. Parneet Cheema and Dr. Peter Ellis discuss the important trials presented at ESMO 2019. 00:01 Introduction of the Best of Oncology Podcast 00:22 Introduction of Dr. Barbara Melosky, Dr. Parneet Cheema and Dr. Peter Ellis 01:33 LBA5 FLAURA OS 13:47 IMpower110 Study 19:06 LBA4 Checkmate 227 28:13 Small cell lung cancer - IMpower133, CASPIAN PD-L1

In this episode, we'll listen to Dr. Barbara Melosky, Dr. Parneet Cheema and Dr. Peter Ellis discuss the important trials presented at ESMO 2019. 00:01 Introduction of the Best of Oncology Podcast 00:22 Introduction of Dr. Barbara Melosky, Dr. Parneet Cheema and Dr. Peter Ellis 01:33 LBA5 FLAURA OS 13:47 IMpower110 Study 19:06 LBA4 Checkmate 227 28:13 Small cell lung cancer - IMpower133, CASPIAN PD-L1

Highlights from the 2019 ESMO Annual Meeting - Lung Cancer

In this episode, we'll listen to Dr. Kala Sridhar, Dr. Sebastien Hotte and Dr. Petras Grivas discuss the important trials presented at ESMO 2019. 00:01 Introduction of the Best of Oncology Podcast 00:29 Introduction of Dr. Kala Sridhar, Dr. Sebastien Hotte and Dr. Petras Grivas 01:30 Bladder/Urothelial Cancer - EV-103 Trial, TROPHY-U-01 STUDY, IMvigor130, BISCAY Trial, NABUCCO Trial 27:38 Prostate Cancer - Phase III SPARTAN Study, STAMPEDE, PROfound Trial, CARD Trial, CCTG IND 232 Trial 52:37 Renal cell carcinoma - ENTRATA Trial

In this episode, we'll listen to Dr. Kala Sridhar, Dr. Sebastien Hotte and Dr. Petras Grivas discuss the important trials presented at ESMO 2019. 00:01 Introduction of the Best of Oncology Podcast 00:29 Introduction of Dr. Kala Sridhar, Dr. Sebastien Hotte and Dr. Petras Grivas 01:30 Bladder/Urothelial Cancer - EV-103 Trial, TROPHY-U-01 STUDY, IMvigor130, BISCAY Trial, NABUCCO Trial 27:38 Prostate Cancer - Phase III SPARTAN Study, STAMPEDE, PROfound Trial, CARD Trial, CCTG IND 232 Trial 52:37 Renal cell carcinoma - ENTRATA Trial

Highlights from the 2019 ESMO Annual Meeting - Genitourinary Cancer

In this episode, we'll listen to Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick discuss the important trials presented at ESMO 2019. 00:01 Introduction of the Best of Oncology Podcast 00:30 Introduction of Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick 01:19 BEACON Trial 08:52 Circulating Tumour DNA Trial - IDEA Trial and 522O 20:08 ATTRACTION-3 Study 27:30 ANGEL study 32:35 KEYNOTE-062 36:12 CheckMate 459 Trial 42:27 ClarIDHy Trial

In this episode, we'll listen to Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick discuss the important trials presented at ESMO 2019. 00:01 Introduction of the Best of Oncology Podcast 00:30 Introduction of Dr. Scott Berry, Dr. Sharlene Gill and Dr. Florian Lordick 01:19 BEACON Trial 08:52 Circulating Tumour DNA Trial - IDEA Trial and 522O 20:08 ATTRACTION-3 Study 27:30 ANGEL study 32:35 KEYNOTE-062 36:12 CheckMate 459 Trial 42:27 ClarIDHy Trial

Highlights from the 2019 ESMO Annual Meeting - Gastrointestinal Cancer

In this episode we’ll listen in on a conversation that Dr. Sunil Verma, Medical Director of the Tom Baker Cancer Centre, Dr. Sara Tolaney Associate Director of the Susan F. Smith Center for Women's Cancers at the Dana Farber Cancer Institute, and Dr. Christine Simmons Medical Oncologist with the British Columbia Cancer Agency, had at the 2019 Best of San Antonio Breast Cancer Symposium in Toronto, where they shared their thoughts on the most impactful data released in HER2 Positive Breast Cancer at the flagship meeting a few weeks earlier.

In this episode we’ll listen in on a conversation that Dr. Sunil Verma, Medical Director of the Tom Baker Cancer Centre, Dr. Sara Tolaney Associate Director of the Susan F. Smith Center for Women's Cancers at the Dana Farber Cancer Institute, and Dr. Christine Simmons Medical Oncologist with the British Columbia Cancer Agency, had at the 2019 Best of San Antonio Breast Cancer Symposium in Toronto, where they shared their thoughts on the most impactful data released in HER2 Positive Breast Cancer at the flagship meeting a few weeks earlier.

Highlights from the 2018 San Antonio Breast Cancer Symposium - HER2 Positive Breast Cancer

In this episode we’ll listen in on a conversation that Dr. Sunil Verma, Medical Director of the Tom Baker Cancer Centre, Dr. Sara Tolaney Associate Director of the Susan F. Smith Center for Women's Cancers at the Dana Farber Cancer Institute, and Dr. Christine Simmons Medical Oncologist with the British Columbia Cancer Agency, had at the 2019 Best of San Antonio Breast Cancer Symposium in Toronto, where they shared their thoughts on the most impactful data released in Hormone Receptor Positive Breast Cancer at the flagship meeting a few weeks earlier.

In this episode we’ll listen in on a conversation that Dr. Sunil Verma, Medical Director of the Tom Baker Cancer Centre, Dr. Sara Tolaney Associate Director of the Susan F. Smith Center for Women's Cancers at the Dana Farber Cancer Institute, and Dr. Christine Simmons Medical Oncologist with the British Columbia Cancer Agency, had at the 2019 Best of San Antonio Breast Cancer Symposium in Toronto, where they shared their thoughts on the most impactful data released in Hormone Receptor Positive Breast Cancer at the flagship meeting a few weeks earlier.

Highlights from the 2018 San Antonio Breast Cancer Symposium - Hormone Receptor Positive Breast Cancer

The best episodes for anyone looking to learn more about topics such as happiness, fulfillment, depression and psychology/mental health in general. With interviews with industry experts, personal stories of individuals, this topic has lessons applicable to everyone. Add episodes you're interested into your queue below!

Best Episodes on Mental Health, Emotions & Thoughts

The best podcasts about ourselves as well as the world through the lense of Science. Specific topics include things about our brain, emotions to biology, physics and more!